MELVILLE, NY —
OSHA Inspection: MELVILLE BIOLOGICS, DIV. OF NEW YORK BLOOD CENTER
Referral inspection · Health discipline
At a glance
On , OSHA opened a referral health inspection of MELVILLE BIOLOGICS, DIV. OF NEW YORK BLOOD CENTER in 155 DURYEA RD., MELVILLE, NY 11747 (NAICS 000000). OSHA activity number 102884293.
OSHA opens inspections for many reasons — routine scheduling under a national or local emphasis program, an employee complaint or referral, or a follow-up after a reported injury. Opening or conducting an inspection is not itself an allegation or a finding that this employer broke any rule; any findings appear as the citations listed below, and citations can be contested, reduced, or withdrawn.
Where did this inspection happen?
- Establishment
- MELVILLE BIOLOGICS, DIV. OF NEW YORK BLOOD CENTER
- Site address
- 155 DURYEA RD.
- City
- MELVILLE
- State
- NY
- ZIP
- 11747
What kind of inspection was it?
- Inspection type
- Referral (C)
- Scope
- Complete (A)
- Discipline
- Health
- Advance notice
- No
- Union status
- Y
When did the case open and close?
- Opened
- Closing conference
- Case closed
- Data loaded
Establishment context
- NAICS code
- 000000
- SIC code (legacy)
- 8099
- Employees
- 370
- Ownership type
- A
Citations
5 citations on file for this inspection.
1910.132 A
- Issued
- Apr 2, 1991
- Abate by
- Dec 10, 1991
- Penalty
- Initial $800 · Current $300 Reduced
Recent events (2)
- — J (S) $300.00
- — Z (S) $800.00
1910.132 B
- Issued
- Apr 2, 1991
- Abate by
- Dec 10, 1991
- Penalty
- Initial $800 · Current $300 Reduced
Recent events (2)
- — J (S) $300.00
- — Z (S) $800.00
1910.141 A04 I
- Issued
- Apr 2, 1991
- Abate by
- Apr 17, 1991
- Penalty
- Initial $800 · Current $300 Reduced
Recent events (2)
- — J (S) $300.00
- — Z (S) $800.00
1910.145 F08 I
- Issued
- Apr 2, 1991
- Abate by
- Dec 10, 1991
- Penalty
- Initial $800 · Current $200 Reduced
Recent events (2)
- — J (S) $200.00
- — Z (S) $800.00
5(a)(1)
- Issued
- Apr 2, 1991
- Abate by
- Dec 10, 1991
- Penalty
- Initial $10,000 · Current $4,000 Reduced
General-duty citation text
Section 5(a)(1) of the Occupational Safety and Health Act of 1970: The employer did not furnish employment and a place of employment which were free from recognized hazards that were causing or likely to cause death or serious physical harm to employees in that employee(s) were exposed to the hazard of becoming infected with Hepatitis B Virus (HBV) and/or Human Immunodeficiency Virus (HIV) through possible direct contact with blood or other body fluids. a) Long Island Blood Services and Melville Biologics, Divisions of New York Blood Center, Inc.: Employees with job titles of Phlebotomists, Laboratory Technicians, Fractionation Technicians, Maintenace Personnel and Engineering staff who were subject of an exposure incident resulting from either a skin puncture from a sharp contaminated with blood or other body fluids or splashes to the eyes and face of blood or other body fluids were not provided with training and information concerning the hazards of such an exposure incident. The employer had not implemented the CDC HIV Follow-Up Procedures necessary when employees are involved in a blood or other body fluid exposure incident. Such employees were not adivised of nor did they have the opportunity to participate in the HIV Follow-Up Procedures, established by the Centers for Disease Control (CDC), when such an exposure occurs; On or about 10/30/90. b) Long Island Blood Services and Melville Biologics, Divisions of New York Blood Center, Inc.; Employees with job titles of Phlebotomist, Laboratory Technicians, Fractionation Technicians, Maintenance Personnel and Engineering staff received no training and education in Universal Precautions and Infection Control as outlined in the 1988 CDC Guidelines. The employers training program only addressed Hepatitis B Vaccination as outlined by the 1985 CDC Guidlines. Employees were not instructed nor did they receive training or an explanation of work practices that will prevent or reduce exposure to blood or other body fluids, including engineering controls, administrative controls and appropriate personal protective equipment (PPE); On or about 10/3/90. c) Long Island Blood Services and Melville Biologics, Divisions ofNew York Blood Center, Inc.; Employees with the job title of Laboratory Technician and Fractionation Technician were required to use a container equipped with a hypodermic clipping device to dispose of contaminated sharpts. This mechanical process exposed employees to skin punctures from contaminated sharps and aerosals of blood or other body fluids; On or about 10/30/90. d) Long Island Blood Services and Melville Biologics, Divisions of New York Blood Center, Inc.; Employees with the job title of Phlebotomist were required to cut needles by hand from the plastic tubing connected to blood donor bags which exposed them to skin punctures from contaminated needles and aerosals of blood or other body fluids; On or about 10/30/90. e) Long Island Blood Services and Melville Biologics, Divisions of New York Blood Center, Inc.; Employees with the job title of Phlebotomist and Laboratory Technicians were exposed to aerosolization of blood or other body fluids while performing snip-n-clip procedures and while hematroning the segments on blood bags and were not protected by plastic barriers or shields; On or about 10/30/90. The hazards of such exposure include, but are not limited to, the onset of clinical symptoms of acute Hepatitis B, anorexia, abdominal pain, jaundice and the potential for becoming a chronic carrier of the Hepatitis B and/or Human Immunodeficiency Virus. ABATEMENT NOTES: Among other methods, one feasible abatement method to reduce this hazard is to establish and enforce adequate procedures regarding exposure to and handling of blood or other body fluids, such as those stipulated by the Centers for Disease Control (CDC) Guidelines published in the Morbidity and Mortality Weekly Report, June 24, 1988, Volume 37, Number 24. Elements essential to an Infection Control Program include at a minimum: TRAINING AND EDUCATION Training and education of employee(s) such as, but not limited to, Phlebotomists, Fractionation Technicians, Laboratory Technicians, Maintenance Personnel and Engineering Staff. Such training and education shall be at the time of initial employment and at least annually thereafter. The training materials used shall be appropriate in content and vocabulary to educational level, literacy, and language background of the employees being trained. The Training and Education Program shall contain, as a minimum, the following elements: i) An explanation of the employer's Infection Control Program; ii) An explanation of the use and limitations of work practices that will prevent or reduce employee exposure, including appropriate engineering controls, work practices and personal protective equipment. iii) An explanation of the basis for selection of personal protective equipment; iv) An explanation of the procedures to be followed if an exposure incident occurs, including the method of reporting the incident and the medical follow-up that will be made available; v) An explanation of the signs and labels and/or color coding used in the workplace; and vi) A copy of the Center for Disease Control (CDC) Guidelines. WRITTEN INFECTION CONTROL PROGRAM The employer's written Infection Control Program shall be designed and implemented to minimize or eliminate employee exposure. This Infection Control Program shall be reviewed and updated as necessary to reflect significan changes in tasks or procedures. This program shall contain, as a minimum, the following: i) A determination of the exposure potential of all employees; ii) The schedule and method of implementation of the Infection Control Program. iii) All the items related to the identifcation, evaluation and control of bloodborne pathogens and exposure to blood and body fluids contained in the employer's Infection Control Training and Information Program must be incorporated in the establishment's overall written Infection Control Program. The written Infection Control Program shal be made available to all employees during the training program. ENGINEERING, ADMINISTRATIVE AND WORKPRACTICE CONTROL i) Notify and person who handles, transports, cleans or launders protective clothing in writing of the potential harmful effects of the exposure to blood and body fluids. ii) Provide platic barriers or shields when Phlebotomists and Laboratory Technicians are performing the snip-n-clip procedures and the hematroning of segments on blood bags. iii) Provide Phlebotomists, Fractionation Technicians and Laboratory Technicians with puncture resistant/fluid resistant sharps containers to prevent bending or breaking of sharps: FOLLOW-UP PROCEDURES AFTER POSSIBLE EXPOSURE TO HIV/HBV: Follow-up procedures shall be taken for employees exposed or potentially exposed to HIV/HBV. The type of procedures depends on the immunization status of the worker (i.e., whether HBV vaccination has been received and antibody response is adequate) and the HBV serologic status of the source patient. The CDC Immunization Practices Advisory Committee has published its recommendations regarding HBV post-exposure prophylaxis in table format in the June 5, 1985, Morbidity and Mortality Weekly Report. If an employee refuses to submit to the procedures when such procedures are medically indicated, no adverse action can be taken on that ground alone since the procedures are designed for the benefit of the exposed employee. HANDLING OF LINEN?REUSABLE PERSONAL PROTECTIVE EQUIPMENT (PPE) The Infection Control Program shall have identified all laundry operations involving substantial risk of direct exposure to blood or body fluids. Linen or reusable Personal Protective Equipment soiled with blood or body fluids shall be handles as little as possible and with minimum agitation to prevent contamination of the person handling the linen/reusable Personal Protective Equipment. All soiled linen or reusable Personal Protective Equipment shall be bagged at the location where it was used. Soiled linen or reusable Personal Protective Equipment shall be placed and transported in bags that prevent leakage.
Recent events (4)
- — I $4125.00
- — Z $8250.00
- — J (U) $4000.00
More inspections at Melville Biologics, DIV. of NEW York Blood Center
View Melville Biologics, DIV. of NEW York Blood Center's full OSHA safety record →
More inspections in this industry (NAICS 000000)
More inspections in NY
Source
This record is reproduced from the U.S. Department of Labor Open Data API (OSHA inspection dataset). The original IMIS detail view is available at OSHA's Establishment Search for activity number 102884293.
Look up any company's OSHA accident reports by company, or browse severe injury reports by year, state, and company.